Header Logo

Connection

Idoroenyi Amanam to Aged, 80 and over

This is a "connection" page, showing publications Idoroenyi Amanam has written about Aged, 80 and over.
Connection Strength

0.379
  1. Immune thrombocytopenia after immune checkpoint inhibitor therapy. Br J Haematol. 2021 05; 193(3):677-681.
    View in: PubMed
    Score: 0.149
  2. Risk prediction for clonal cytopenia: multicenter real-world evidence. Blood. 2024 Nov 07; 144(19):2033-2044.
    View in: PubMed
    Score: 0.048
  3. Genomic Landscape of Myelodysplastic/Myeloproliferative Neoplasms: A Multi-Central Study. Int J Mol Sci. 2024 Sep 23; 25(18).
    View in: PubMed
    Score: 0.048
  4. Precision medicine and actionable alterations in lung cancer: A single institution experience. PLoS One. 2020; 15(2):e0228188.
    View in: PubMed
    Score: 0.035
  5. Mutation and immune profiling of metaplastic breast cancer: Correlation with survival. PLoS One. 2019; 14(11):e0224726.
    View in: PubMed
    Score: 0.034
  6. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. Ann Oncol. 2019 07 01; 30(7):1096-1103.
    View in: PubMed
    Score: 0.033
  7. Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma. Am J Clin Oncol. 2019 04; 42(4):337-344.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.